Contains Lipospheric Ascorbic Acid 330mg/mL
It is a dual GLP-1 and GIP receptor agonist, which means it acts on two hormone pathways involved in fullness, insulin response, blood sugar regulation, and appetite control
Identifying personal barriers, socioeconomic factors, education, and self-efficacy to improve disease risk and weight loss are crucial to the long-term success and benefits these medications provide
Research is currently underway to see if taking oral weight-loss medication (such as bupropion-naltrexone) can help ease the transition off GLP-1 receptor agonists and reduce the amount of weight that's typically regained after stopping them
In animal reproduction studies, adverse effects on development were observed following intranasal administration of dihydroergotamine mesylate during pregnancy (decreased fetal body weight and/or skeletal ossification) in rats and rabbits or during pregnancy and lactation in rats (decreased body weight and impaired reproductive function in the offspring) at doses that were not associated with maternal toxicity (see Data)
Anabolic Steroid Withdrawal Dependence and withdrawal are two phenomena commonly associated with drugs of abuse (Hochberg et al, 2003)
